MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino, Stefania; Lamorte, Daniela; Caivano, Antonella; Laurenzana, Ilaria; Tagliaferri, Daniela; Falco, Geppino; Del Vecchio, Luigi; Musto, Pellegrino; De Luca, Luciana.
Int J Mol Sci
; 19(2)2018 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-29401684
How One Thing Led to Another.
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.
Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family.
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.
A critical role of epigenetic inactivation of miR-9 in EVI1<sup>high</sup> pediatric AML.
Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development.
MicroRNA: an important regulator in acute myeloid leukemia.
ICM: a web server for integrated clustering of multi-dimensional biomedical data.